SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NexStar Pharm(NXTR)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Chris Boylan who wrote (320)3/4/1999 1:25:00 AM
From: Miljenko Zuanic  Read Replies (1) of 328
 
Chris:

<<This proposed buyout is, at best, poorly timed and ill-conceived.>>

Why? And for whom?

In short and imo ( I know both company very well), if anyone is to blame for NXTR performance in last two years it is company management. Merge (I see this as merge of bigger and smaller) with GILD is positive for both company (each has good and bad points) and NXTR SH will benefit more than from NXTR standalone.

Miljenko
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext